top of page

Shaping the future of pharmaceutical manufacturing – see how
Dalas Biotech can help power your next Project.

FACILITY

A world-class manufacturing campus built for Scale, Precision, and Sustainability.

State-of-the-Art Pharmaceutical Manufacturing

Based in Bhiwadi, Rajasthan, is designed for large-scale production of bulk antibiotics, intermediates, and enzymes. With a fully integrated process, we prioritize purity, efficiency, and sustainability, ensuring a reliable supply of high-quality pharmaceutical ingredients to meet global demand.

iStock-2177384826.jpg

10,000T+

combined unit annual production capacity

30+

countries served via our vast Export Network 

99.8%

batch purity achieved through advanced quality control processes

DBT Export Network.png

Our Export Network

othercertifications.png
othercertifications.png

Quality Standards 

Dalas Biotech

adheres to the highest international quality standards, ensuring regulatory compliance, exceptional product stability, and preparedness for high-value global markets.

whocgmp.png
  • Products meet IP/BP/EP/USP specifications, ensuring compatibility across multiple markets.

  • Manufacturing processes align with stringent international quality benchmarks.

WHO-GMP Certified Facilities

Fully compliant with global pharmaceutical manufacturing standards.

Ensures product safety, efficacy, and reliability for domestic and international markets.

Amoxicillin Unit

1.png
2.png

High-Capacity, Bio-Reaction Facility

One of the very few facilities in the world capable of large-scale enzymatic Amoxicillin production, ensuring high purity, controlled processing, and unmatched capacity.

3.png

-60°C to 100°C

precision temperature control for optimal reaction conditions

6,000T+

annual production capacity

15

Advanced Reactors ranging from 0.7KL to 10KL

Ampicillin Unit

4.png
5.png

High-Purity, Cost-Effective Production

The largest enzymatic Ampicillin production facility in India, ensuring high efficiency, continuous processing, and cost-effective output with uncompromised quality.

6.png

State-of-Art

Bio-generic Processes

1,200T+

annual production capacity

Fully Segregated

and Dedicated Manufacturing Unit

Intermediate Unit

7.png
8.png

Built for Efficiency & Global Expansion

A fully GMP-compliant facility designed for high-yield, multi-stage reactions, maximising efficiency and enabling export-driven growth, with optimised production timelines.

11.png

Dedicated & Segregated

Penicillin Site Chain Facility

2,800T+

annual production capacity

20+

Countries Served

Fermentation Unit

10.png
12.png

Enzyme & Biotech Manufacturing

A state-of-the-art fermentation facility designed for large-scale enzyme, protein, and secondary metabolite production, enabling both pilot and commercial-scale biotech manufacturing.

13.png

20L-20,000L

Fermentation Capability in Batch Reactors

Multiple

Downstream Capabilities

4

High Capacity Bio-Fermenters

bottom of page